I am a mathematician turned statistician. My primary interest is in early phase trials and adaptive designs, hopefully with a bit of Bayesian somewhere in there.

A lot of my time is spent designing, setting up, monitoring and analysing clinical trials - looking particularly at the efficacy and safety of treatments. I am also part of the CSM Early Phase Team, where we meet to discuss new analysis techniques and recently developing methodologies and how we could potentially implement these in a clinical setting.